CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474790334
- Phone
- 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-10 | Williams Michelle LeRoux CHIEF SCIENTIFIC OFFICER | Option exercise | +12,500 | 130,552 | ||
| 2026-09-10 | Williams Michelle LeRoux CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −4,269 | $0.80 | $3K | 126,283 |
| 2026-09-10 | Williams Michelle LeRoux CHIEF SCIENTIFIC OFFICER | Option exercise · Restricted Stock Units | −12,500 | 12,500 | ||
| 2026-09-10 | Mills C Randal PRESIDENT AND CEO | Option exercise | +27,083 | 474,113 | ||
| 2026-09-10 | Mills C Randal PRESIDENT AND CEO | Shares withheld for taxes | −9,718 | $0.80 | $8K | 464,395 |
| 2026-09-10 | Mills C Randal PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −27,083 | 189,583 | ||
| 2026-09-10 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Option exercise | +12,500 | 494,389 | ||
| 2026-09-10 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −4,486 | $0.80 | $4K | 489,903 |
| 2026-09-10 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −12,500 | 12,500 | ||
| 2026-06-21 | Mills C Randal PRESIDENT AND CEO | Option exercise | +22,473 | 449,244 | ||
| 2026-06-21 | Mills C Randal PRESIDENT AND CEO | Shares withheld for taxes | −8,064 | $1.06 | $9K | 441,180 |
| 2026-06-21 | Mills C Randal PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −22,473 | 0 | ||
| 2026-06-11 | Colpman David Director | Grant or award · Stock Option (Right to Buy) | +106,393 | 106,393 | ||
| 2026-06-11 | Makes Brigid Director | Grant or award · Stock Option (Right to Buy) | +106,393 | 106,393 | ||
| 2026-06-11 | NEELS GUIDO J Director | Grant or award · Stock Option (Right to Buy) | +106,393 | 106,393 | ||
| 2026-06-11 | RAKIN KEVIN Director | Grant or award · Stock Option (Right to Buy) | +159,590 | 159,590 | ||
| 2026-06-10 | Williams Michelle LeRoux CHIEF SCIENTIFIC OFFICER | Option exercise | +12,500 | 122,321 | ||
| 2026-06-10 | Williams Michelle LeRoux CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −4,269 | $1.04 | $4K | 118,052 |
| 2026-06-10 | Williams Michelle LeRoux CHIEF SCIENTIFIC OFFICER | Option exercise · Restricted Stock Units | −12,500 | 25,000 | ||
| 2026-06-10 | Mills C Randal PRESIDENT AND CEO | Option exercise | +27,083 | 436,489 |
Page 1 of 17 · 323 trades